AI assistant
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2021
Apr 2, 2021
32130_dirs_2021-04-02_193ae3ca-fe2b-4bde-8fb5-ec1e910640a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2021-04-01
Reporting Person: Novack David F (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Common Stock | A | 2500 | $3.39 | Acquired | 137399 | Direct |
| 2021-04-01 | Common Stock | S | 20000 | $9.92 | Disposed | 117399 | Direct |
Footnotes
F1: Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 12, 2021
F2: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
F3: This transaction was executed in multiple trades at prices ranging from $9.77 to $10.00; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.